California State Teachers Retirement System Holds Stake in Neogen (NEOG); Bristol (BMY) Shareholder Clifford Swan Investment Counsel Has Decreased Position as Market Valuation Declined

June 14, 2018 - By Ellis Scott

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Clifford Swan Investment Counsel Llc decreased its stake in Bristol (BMY) by 1.4% based on its latest 2018Q1 regulatory filing with the SEC. Clifford Swan Investment Counsel Llc sold 6,216 shares as the company’s stock declined 23.11% with the market. The institutional investor held 439,344 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $27.79 million, down from 445,560 at the end of the previous reported quarter. Clifford Swan Investment Counsel Llc who had been investing in Bristol for a number of months, seems to be less bullish one the $87.53B market cap company. The stock increased 0.17% or $0.09 during the last trading session, reaching $53.55. About 2.67 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 2.98% since June 14, 2017 and is downtrending. It has underperformed by 15.55% the S&P500. Some Historical BMY News: 15/03/2018 – EXELIXIS SUBMITS U.S. SNDA FOR CABOMETYX® (CABOZANTINIB) FOR PR; 06/04/2018 – Incyte and Merck Provide Update on Phase 3 Study of Epacadostat in Combination With KEYTRUDA(R) (pembrolizumab) in Patients With Unresectable or Metastatic Melanoma; 23/05/2018 – Merck: Keytruda Has Shown Improved Survival Benefit in Advanced NSCLC in Five Phase 3 Trials; 14/03/2018 – Rhode Island DoA: Bristol Town Council Wed, 3/14/2018, 8:00 PM; 17/05/2018 – Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Phase 2 Second Line Pancreatic Cancer Study; 27/03/2018 – BRISTOL-MYERS SQUIBB CO – FDA ALSO GRANTED OPDIVO PLUS YERVOY COMBINATION BREAKTHROUGH THERAPY DESIGNATION FOR THIS POTENTIAL INDICATION; 22/05/2018 – REG-University of Bristol signs agreement with cBrain; 12/03/2018 – Epizyme Appoints Oncology Industry Leader Michael Giordano, M.D., to its Board of Directors; 19/04/2018 – #3 Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a $9B organization $NVS; 26/04/2018 – BMY FIRST QUARTER EARNINGS CALL BEGINS

California State Teachers Retirement System increased its stake in Neogen Corp (NEOG) by 30.59% based on its latest 2018Q1 regulatory filing with the SEC. California State Teachers Retirement System bought 17,896 shares as the company’s stock rose 22.25% while stock markets declined. The institutional investor held 76,407 shares of the in vitro & in vivo diagnostic substances company at the end of 2018Q1, valued at $5.12M, up from 58,511 at the end of the previous reported quarter. California State Teachers Retirement System who had been investing in Neogen Corp for a number of months, seems to be bullish on the $4.13B market cap company. The stock increased 1.23% or $0.97 during the last trading session, reaching $80.04. About 91,070 shares traded. Neogen Corporation (NASDAQ:NEOG) has risen 56.69% since June 14, 2017 and is uptrending. It has outperformed by 44.12% the S&P500.

Investors sentiment increased to 6.71 in Q1 2018. Its up 5.22, from 1.49 in 2017Q4. It increased, as 13 investors sold NEOG shares while 15 reduced holdings. 27 funds opened positions while 161 raised stakes. 90.94 million shares or 167.86% more from 33.95 million shares in 2017Q4 were reported. 592,794 are held by Bamco Ny. Qs Ltd Company holds 1,079 shares or 0% of its portfolio. Creative Planning has invested 0% in Neogen Corporation (NASDAQ:NEOG). California Pub Employees Retirement Systems holds 131,853 shares or 0.01% of its portfolio. Cornerstone Advsr Inc, Washington-based fund reported 15 shares. Hightower Advsr Ltd Liability Corp reported 0% of its portfolio in Neogen Corporation (NASDAQ:NEOG). North Carolina-based Retail Bank Of America Corporation De has invested 0% in Neogen Corporation (NASDAQ:NEOG). King Luther Corporation accumulated 958,914 shares. Bb&T Corporation holds 6,757 shares. Blackrock Inc invested 0.02% of its portfolio in Neogen Corporation (NASDAQ:NEOG). Invesco Limited accumulated 466,434 shares. Fdx Advsrs reported 0.01% in Neogen Corporation (NASDAQ:NEOG). North Point Portfolio Managers Corp Oh reported 243,536 shares. First Tru Advsrs Lp invested in 27,845 shares. Riverhead Capital Ltd Liability accumulated 4,179 shares.

Since January 26, 2018, it had 0 insider purchases, and 16 insider sales for $10.42 million activity. Quinlan Steven J. sold $359,092 worth of Neogen Corporation (NASDAQ:NEOG) on Monday, May 7. PAPESH G BRUCE sold $358,320 worth of stock. 10,000 shares valued at $574,954 were sold by HERBERT JAMES L on Thursday, February 15. 14,800 shares valued at $1.00M were sold by MORRICAL TERRI A on Friday, April 6. BRADLEY EDWARD sold $706,950 worth of Neogen Corporation (NASDAQ:NEOG) on Friday, January 26. $374,818 worth of stock was sold by REED THOMAS H on Friday, March 23.

California State Teachers Retirement System, which manages about $46.70B US Long portfolio, decreased its stake in Mcdonald S Corp (NYSE:MCD) by 43,528 shares to 1.38M shares, valued at $215.88M in 2018Q1, according to the filing. It also reduced its holding in Marsh Mclennan Cos (NYSE:MMC) by 35,687 shares in the quarter, leaving it with 832,309 shares, and cut its stake in Progressive Corp (NYSE:PGR).

Among 5 analysts covering Neogen (NASDAQ:NEOG), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Neogen had 7 analyst reports since August 26, 2015 according to SRatingsIntel. Zacks downgraded the shares of NEOG in report on Wednesday, August 26 to “Buy” rating. The stock of Neogen Corporation (NASDAQ:NEOG) has “Hold” rating given on Monday, March 26 by Stephens. The stock of Neogen Corporation (NASDAQ:NEOG) earned “Hold” rating by Craig Hallum on Tuesday, December 22. Roth Capital maintained the stock with “Hold” rating in Thursday, January 4 report. The firm has “Hold” rating given on Tuesday, September 22 by Zacks.

More news for Neogen Corporation (NASDAQ:NEOG) were recently published by: Nasdaq.com, which released: “Consolidated Research: 2018 Summary Expectations for TrueCar, Roadrunner Transportation, Eldorado Gold, Neogen …” on May 17, 2018. Nasdaq.com‘s article titled: “Market Trends Toward New Normal in Neogen, Intuitive Surgical, IDT, Government Properties Income Trust, Everbridge …” and published on June 13, 2018 is yet another important article.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.11, from 0.94 in 2017Q4. It dropped, as 64 investors sold BMY shares while 573 reduced holdings. 111 funds opened positions while 418 raised stakes. 1.12 billion shares or 1.08% more from 1.11 billion shares in 2017Q4 were reported. Tocqueville Asset Mgmt LP reported 652,486 shares. 1,308 are owned by Wealthtrust. Arizona State Retirement Sys has 0.26% invested in Bristol-Myers Squibb Company (NYSE:BMY). Old National State Bank In accumulated 0.3% or 91,353 shares. 371,225 are held by Kbc Grp Nv. Salzhauer Michael has 0.07% invested in Bristol-Myers Squibb Company (NYSE:BMY). Bb&T holds 0.31% in Bristol-Myers Squibb Company (NYSE:BMY) or 258,382 shares. Moreover, Wendell David Assocs has 0.2% invested in Bristol-Myers Squibb Company (NYSE:BMY). Waddell Reed Fin Inc holds 448,040 shares. Corbyn Management Md reported 150 shares. Teacher Retirement Systems Of Texas holds 0.33% or 771,095 shares in its portfolio. Atria Invests Ltd Com holds 52,765 shares or 0.16% of its portfolio. Tru Of Oklahoma invested in 3,917 shares or 0% of the stock. Carnegie Cap Asset Lc owns 102,714 shares. Peak6 Investments Limited Partnership owns 0.01% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 49,949 shares.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on July, 26. They expect $0.87 EPS, up 17.57% or $0.13 from last year’s $0.74 per share. BMY’s profit will be $1.42B for 15.39 P/E if the $0.87 EPS becomes a reality. After $0.94 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -7.45% negative EPS growth.

Since December 15, 2017, it had 1 buy, and 0 selling transactions for $249,948 activity. Another trade for 4,770 shares valued at $249,948 was made by Paliwal Dinesh C on Monday, April 30.

Clifford Swan Investment Counsel Llc, which manages about $2.29 billion and $1.77 billion US Long portfolio, upped its stake in Vodafone Group Plc New (NASDAQ:VOD) by 31,081 shares to 176,887 shares, valued at $4.92M in 2018Q1, according to the filing. It also increased its holding in Schlumberger Ltd (NYSE:SLB) by 5,307 shares in the quarter, for a total of 354,052 shares, and has risen its stake in Allergan Inc.

Among 22 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 2 Sell and 14 Hold. Therefore 27% are positive. Bristol-Myers Squibb Company had 87 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Hold” rating given on Tuesday, September 12 by Hilliard Lyons. The stock has “Neutral” rating by Bank of America on Tuesday, April 17. Cowen & Co maintained it with “Hold” rating and $6500 target in Monday, August 14 report. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Leerink Swann on Tuesday, February 6. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Overweight” rating by Morgan Stanley on Thursday, February 15. The firm earned “Sell” rating on Wednesday, August 16 by BMO Capital Markets. The firm has “Underweight” rating given on Friday, December 18 by Atlantic Securities. Citigroup maintained the shares of BMY in report on Wednesday, October 18 with “Buy” rating. The firm earned “Buy” rating on Monday, October 30 by SunTrust. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, March 23 with “Hold” rating.

Neogen Corporation (NASDAQ:NEOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ellis Scott

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts